Ovarian cancer is the second most common cause of gynecologic cancer death in women
around the world. The outcomes are complicated, because the disease is often diagnosed …

Of all the gynecologic tumors, ovarian cancer (OC) is known to be the deadliest. Advanced‐
stages of OC are linked with high morbidity and low survival rates despite the immense …

The diagnosis and treatment planning for newly diagnosed ovarian adenocarcinomas are
unique among solid cancers. Ovarian cancer is insidious in presentation with few sentinel …

Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the
United States, with less than half of patients living> 5 years from diagnosis. A major …

Ovarian carcinoma is characterized by heterogeneity at the molecular, cellular and
anatomical levels, both spatially and temporally. This heterogeneity affects response to …

Intercellular communication is a normal feature of most physiological interactions between
cells in healthy organisms. While cells communicate directly through intimate physiology …

The advent of polyadenosine diphosphate ribose polymerase inhibitors (PARPi) has
brought about significant changes in the field of ovarian cancer treatment. However, in 2022 …

ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …

Introduction. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel drug
delivery system with superior pharmacological properties for treating peritoneal metastasis …

Ovarian cancer remains the leading cause of death from gynecological cancer. Survival is
significantly related to the stage of the disease at diagnosis. Of quite importance is primary …